This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsLet’s ConnectStock Hub

Example content

Menu

Close

Non-valvular atrial fibrillation (NVAF)Venous thromboembolism (VTE)Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Click here for Eliquis® (apixaban) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

Cardiovascular Disease
The NHS Long Term Plan has identified cardiovascular disease (CVD) as the single biggest condition where the NHS can save lives with the opportunity to prevent up to 150,000 heart attacks, strokes and dementia cases over the next 10 years1Non-valvular atrial fibrillation (NVAF)

Non-valvular atrial fibrillation (NVAF) is a common heart arrhythmia, affecting one in 20 people over the age of 65 and one in ten over the age of 752

View site
Loading
Venous thromboembolism (VTE) Venous thromboembolism (VTE) is a condition in which a blood clot forms3

View siteLoading
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Increase your understanding of the causes of the disease, signs and symptoms, diagnostic tools, and current and emerging treatment strategies.

View siteLoading
Video Resources

Explore our Key Opinion Leader (KOL) videos and understand more NVAF and VTE diagnosis and management along with best practice sharing.

View videosLoading
  1. NHS. The NHS Long Term Plan. 2019. Available at https://www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf
  2. Hankey GJ. Non-valvular atrial fibrillation and stroke prevention. Medical Journal of Australia. 2001;174:234–239 Available at: https://pubmed.ncbi.nlm.nih.gov/11280695/ Accessed April 2022
  3. Blann A D et al. BMJ 2006;332:215-9 doi:10.1136/bmj.332.7535.215
PP-ELI-GBR-10150. May 2022

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store


Adverse events should also be reported to Bristol-Myers Squibb via [email protected] or 0800 731 1736 (United Kingdom)​​​​​​​

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc


This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ


Copyright © 2021 Pfizer Limited. All rights reserved.


VAT registration number GB201048427

PP-UNP-GBR-0596. April 2022
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​

OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.

If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.

Would you like to register or sign in now?